192 related articles for article (PubMed ID: 29976394)
1. Synergic effect of curcumin and its structural analogue (Monoacetylcurcumin) on anti-influenza virus infection.
Richart SM; Li YL; Mizushina Y; Chang YY; Chung TY; Chen GH; Tzen JT; Shia KS; Hsu WL
J Food Drug Anal; 2018 Jul; 26(3):1015-1023. PubMed ID: 29976394
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship analysis of curcumin analogues on anti-influenza virus activity.
Ou JL; Mizushina Y; Wang SY; Chuang DY; Nadar M; Hsu WL
FEBS J; 2013 Nov; 280(22):5829-40. PubMed ID: 24034558
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of curcumin on influenza A virus infection and influenzal pneumonia via oxidative stress, TLR2/4, p38/JNK MAPK and NF-κB pathways.
Dai J; Gu L; Su Y; Wang Q; Zhao Y; Chen X; Deng H; Li W; Wang G; Li K
Int Immunopharmacol; 2018 Jan; 54():177-187. PubMed ID: 29153953
[TBL] [Abstract][Full Text] [Related]
4. Semi-continuous Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing the Dynamic Competition To Select Candidates for Antiviral Therapy.
Pelz L; Rüdiger D; Dogra T; Alnaji FG; Genzel Y; Brooke CB; Kupke SY; Reichl U
J Virol; 2021 Nov; 95(24):e0117421. PubMed ID: 34550771
[TBL] [Abstract][Full Text] [Related]
5. Inhibition Effects and Mechanisms of Marine Compound Mycophenolic Acid Methyl Ester against Influenza A Virus.
Wang Z; Sun L; Zhao H; Sow MD; Zhang Y; Wang W
Mar Drugs; 2024 Apr; 22(5):. PubMed ID: 38786581
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Influenza A Virus Infection by Fucoidan Targeting Viral Neuraminidase and Cellular EGFR Pathway.
Wang W; Wu J; Zhang X; Hao C; Zhao X; Jiao G; Shan X; Tai W; Yu G
Sci Rep; 2017 Jan; 7():40760. PubMed ID: 28094330
[TBL] [Abstract][Full Text] [Related]
7. Efficient Inhibition of Avian and Seasonal Influenza A Viruses by a Virus-Specific Dicer-Substrate Small Interfering RNA Swarm in Human Monocyte-Derived Macrophages and Dendritic Cells.
Jiang M; Österlund P; Westenius V; Guo D; Poranen MM; Bamford DH; Julkunen I
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463970
[TBL] [Abstract][Full Text] [Related]
8. Novel Anti-Viral Properties of the Herbal Extract of
Chen YL; Chao PY; Hsieh CF; Hsieh PW; Horng JT
Viruses; 2024 Mar; 16(4):. PubMed ID: 38675866
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory and antiviral activities of cynanversicoside A and cynanversicoside C isolated from Cynanchun paniculatum in influenza A virus-infected mice pulmonary microvascular endothelial cells.
Wei P; Zhang T; Dong H; Chen Q; Mu X; Hu G
Phytomedicine; 2017 Dec; 36():18-25. PubMed ID: 29157813
[TBL] [Abstract][Full Text] [Related]
10. Aurantiamide acetate from baphicacanthus cusia root exhibits anti-inflammatory and anti-viral effects via inhibition of the NF-κB signaling pathway in Influenza A virus-infected cells.
Zhou B; Yang Z; Feng Q; Liang X; Li J; Zanin M; Jiang Z; Zhong N
J Ethnopharmacol; 2017 Mar; 199():60-67. PubMed ID: 28119097
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of JIP4 at S730 Presents Antiviral Properties against Influenza A Virus Infection.
Del Sarto J; Gerlt V; Friedrich ME; Anhlan D; Wixler V; Teixeira MM; Boergeling Y; Ludwig S
J Virol; 2021 Sep; 95(20):e0067221. PubMed ID: 34319782
[TBL] [Abstract][Full Text] [Related]
12. Glucosyl hesperidin prevents influenza a virus replication in vitro by inhibition of viral sialidase.
Saha RK; Takahashi T; Suzuki T
Biol Pharm Bull; 2009 Jul; 32(7):1188-92. PubMed ID: 19571383
[TBL] [Abstract][Full Text] [Related]
13. Inhibition effects of novel polyketide compound PPQ-B against influenza A virus replication by interfering with the cellular EGFR pathway.
Wang M; Wang S; Wang W; Wang Y; Wang H; Zhu W
Antiviral Res; 2017 Jul; 143():74-84. PubMed ID: 28414053
[TBL] [Abstract][Full Text] [Related]
14. 3D-quantitative structure-activity relationship and antiviral effects of curcumin derivatives as potent inhibitors of influenza H1N1 neuraminidase.
Lai Y; Yan Y; Liao S; Li Y; Ye Y; Liu N; Zhao F; Xu P
Arch Pharm Res; 2020 May; 43(5):489-502. PubMed ID: 32248350
[TBL] [Abstract][Full Text] [Related]
15. A77 1726, the active metabolite of the anti-rheumatoid arthritis drug leflunomide, inhibits influenza A virus replication in vitro and in vivo by inhibiting the activity of Janus kinases.
Wang J; Sun J; Hu J; Wang C; Prinz RA; Peng D; Liu X; Xu X
FASEB J; 2020 Aug; 34(8):10132-10145. PubMed ID: 32598086
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of influenza virus replication by adlay tea.
Nagai E; Iwai M; Koketsu R; Sogabe R; Morimoto R; Suzuki Y; Ohta Y; Okuno Y; Ohshima A; Enomoto T; Isegawa Y
J Sci Food Agric; 2018 Mar; 98(5):1899-1905. PubMed ID: 28902408
[TBL] [Abstract][Full Text] [Related]
17. Engineered Small-Molecule Control of Influenza A Virus Replication.
Fay EJ; Aron SL; Stone IA; Waring BM; Plemper RK; Langlois RA
J Virol; 2019 Jan; 93(1):. PubMed ID: 30282710
[TBL] [Abstract][Full Text] [Related]
18. Chemoreactive-Inspired Discovery of Influenza A Virus Dual Inhibitor to Block Hemagglutinin-Mediated Adsorption and Membrane Fusion.
Wu G; Yu G; Yu Y; Yang S; Duan Z; Wang W; Liu Y; Yu R; Li J; Zhu T; Gu Q; Li D
J Med Chem; 2020 Jul; 63(13):6924-6940. PubMed ID: 32520560
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Periodic Treatment of Quercetin against Influenza A Virus H1N1 through Modulation of Protein Expression.
Vaidya B; Cho SY; Oh KS; Kim SH; Kim YO; Jeong EH; Nguyen TT; Kim SH; Kim IS; Kwon J; Kim D
J Agric Food Chem; 2016 Jun; 64(21):4416-25. PubMed ID: 27157719
[TBL] [Abstract][Full Text] [Related]
20. The inhibitory effect of sodium baicalin on oseltamivir-resistant influenza A virus via reduction of neuraminidase activity.
Jin J; Chen Y; Wang D; Ma L; Guo M; Zhou C; Dou J
Arch Pharm Res; 2018 Jun; 41(6):664-676. PubMed ID: 29572682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
